Half-dose bevacizumab appears safe for preventing bleeding prior to vitrectomy
- Posted on: Nov 21 2018
- Leave a response
Investigators evaluated the optimal dose of preoperative intravitreal bevacizumab in patients undergoing vitrectomy for proliferative diabetic retinopathy (PDR).
Source: AAO
Posted in: Uncategorized